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M. Boult,1 W. Babidge,1,3 G. Maddern,1,3* M. Barnes2 and R. Fitridge3 on behalf
of the Audit Reference Group1Australian Safety and Efficacy Register of New Interventional Procedures–Surgical, Royal Australasian
College of Surgeons, Stepney, 2CSIRO Mathematical and Information Sciences, Glen Osmond, and
3Department of Surgery, The Queen Elizabeth Hospital, University of Adelaide, Woodville, SA, AustraliaObjective. Australian cases of endovascular aneurysm repair (EVAR) performed between 1999 and 2001 have been
evaluated to determine the mid-term (6 months to 5 years) safety and efficacy of the procedure. This study looks at predictors
of success, based on mid-term follow-up data.
Design of study. This study uses results obtained from a prospective semi-voluntary register (audit) of Australian data
obtained from surgeons in the private and public sector.
Results. Peri-operative mortality for patients enrolled in the audit was 1.8%. Ninety-three percent of procedures were
technically successful (890/961). Nearly 13% of patients have had re-interventions (mostly endoluminal) at follow-up.
Analysis of audit data shows that the likelihood of experiencing post-operative complications or requiring additional
procedures increases with ASA rating, increasing age, large pre-operative aneurysm size, aneurysm angle O458 and number
of co-morbid conditions diagnosed.
Conclusions. This study confirms satisfactory mid-term results in a, national rather than unit specific, setting. Predictors
of clinical failure or need for re-intervention include large aneurysm size, neck angulation R45 degrees and short infrarenal
neck.Keywords: Aortic aneurysm, abdominal-surgery; Australia; Medical audit; Vascular surgical procedures.Introduction
Following the first endovascular aneurysm repair
(EVAR) by Parodi et al.1 in 1991, the procedure has
been enthusiastically adopted by Australian vascular
surgeons, who have contributed significantly to
knowledge of this procedure. The Zenith graft was
developed in Perth, WA by David Hartley and Michael
Lawrence-Brown and first deployed in 1993. The
Royal Prince Alfred group in Sydney, NSW, led by
James May and Geoffrey White performed their first
procedure in 1992 and have published extensively on
the procedure and outcomes of EVAR.
The Australian audit of EVAR was instigated in
1999 to consider mid to long term safety and
durability. The audit has been managed by the
Australian Safety and Efficacy Register of Newing author. Prof Guy Maddern, PhD FRACS,
P.O. Box 553, Stepney, SA 5069, Australia.
: college.asernip@surgeons.org
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has been in progress for over 4 years.
This paper reviews predictors of early and mid-
term success derived from statistical analysis of the
audit data.Method
ASERNIP-S is a programme of the Royal Australasian
College of Surgeons (RACS) whose remit is to provide
quality and timely assessments of new and emerging
surgical technologies and techniques. When the audit
was established, a reference group of vascular
surgeons was convened to advise ASERNIP-S on
clinical aspects of EVAR repair. Ethics approval for
the audit was obtained from the Ethics Committee for
the Royal Australasian College of Surgeons.
Operative data for patients were requested from all
vascular surgeons who performed EVAR between 1st
November 1999 and 16th May 2001. Follow-up for thisEur J Vasc Endovasc Surg 31, 123–129 (2006)
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Table 1. Reporting standards for technical and clinical success
Description
Technical success Primary technical success based on intent-to-treat basis
Successful access to the arterial system using a remote site
Successful deployment of the endoluminal graft with secure proximal and distal fixation
Absence of death, conversion to open repair, type I or III endoleaks, or graft limb obstruction
Use of additional planned components, stents, angioplasty or adjunctive surgical procedures
constitutes success
Assisted primary success* Additional unplanned endovascular procedure
Secondary technical success* Additional unplanned surgical procedure
Clinical success Successful deployment of device at intended location
Absence of aneurysm-related death, type I or III endoleak, graft infection, thrombosis, aneurysm
expansion R5 mm, aneurysm rupture, conversion to open repair, graft migration, failure of device
integrity
Assisted clinical success Additional endovascular procedures
Secondary clinical success Additional surgical procedures
* The Australian audit data does not distinguish planned and unplanned procedures undertaken during the peri-procedural (24 h) period.
Table 3. Adaptation of Whites grading scale to Australian audit
data
Morphology Extent Points allocated
M. Boult et al.124cohort of patients is continuing. The results presented
here are derived from patient pre-operative, operative
and follow-up information. Ongoing government
funding of EVAR has been made dependent on the
submission of data to the ASERNIP-S audit and over
90% of private cases performed during the audit
period were submitted.
A range of pre-operative data items were collected
including age, gender, co-morbidities, aneurysm
diameter and morphology and pre-operative imaging.
Operative information included anaesthetic tech-
niques, type of graft, peri-operative mortality, intra-
operative and post-operative complications, early
endoleak and duration of post-operative hospital
stay. The American Society of Anaesthesiology (ASA)
classification was used to assess patient fitness for
surgery. Peri-operative mortality was defined as death
within 30 days of the procedure. Follow-up data
collected included imaging techniques, problems
identified by imaging, graft position, aneurysm size
and additional procedures.
Technical and clinical success rates were calculated
according to reporting standards established by the
Ad Hoc Committee for standardized reporting
practices in vascular surgery2 which are summarised
in Tables 1 and 2.
Statistical analyses were undertaken to answer the
following questions:Table 2. Period of technical and clinical success
Period
Technical success Peri- and post-operative to 24 h
Clinical success
Initial Up to 30 days post-operative
Short term 30 days to 6 months
Mid term 6 months to 5 years
Long term O5 years
Eur J Vasc Endovasc Surg Vol 31, 2 20061. What pre- and peri-operative variables affect the
likelihood of complications or re-interventions?
To answer this question, the presence or absence of
complications or interventions after EVAR was
regressed (logistic regression) against key predictor
variables: ASA, age, AAA diameter, number of
comorbidities, suitability for open repair, gender, sac
size change (pre-operative and post-operative), modi-
fied ‘Whites grading system3’ (Table 3), infrarenal neck
length, infrarenal neck diameter, aortic neck angle,
aneurysm angle, device name and type, patient type
(private or public) and smoking status. Complications
included failed access, access vessel complications,
failed deployment, misplaced deployment, imperfect
seal, kink, and embolisation. Other complications
picked up prior to discharge included device, systemic
and access site complications.
2. What aneurysm morphology variables affect the
likelihood of type I and II endoleaks?
Logistic regressions and unpaired t-tests were used
to compare patients with and without endoleaks. After
analysing data from the operative/discharge data sets,
key predictor variables were also regressed againstAortic neck length !15 mm 3
Aortic neck angulation O458 3
Thrombus present 3
Aortic sac angulation O608 3
Severe iliac artery
tortuosity
3
Severe iliac artery
calcification
3
No additional factors were evaluated. Following White’s grading
system, points were allocated as before: Grade I, 1–2 points; grade II,
3–5 points; grade III, O5 points.
Mid-term Predictors of Success for EVAR 125whether a patient had ever had an endoleak in any of
the follow-up reviews.
3. Does presence of type I or II endoleaks affect the
likelihood of another procedure?
Logistic regressions and Fisher’s exact test were
performed to determine whether the presence of type I
or II endoleaks affect the likelihood of a patient
requiring another procedure.
4. What variables affect technical success and clinical
success?
Regressions were performed studying relationships
between technical and clinical success and key
variables: ASA, age, maximum aneurysm diameter,
number of diagnosed conditions, suitability for open
repair, gender, sac size changes, modified ‘Whites
grading system, infrarenal neck length, infrarenal neck
diameter, aortic neck angle, name of device, type of
graft, patient type (public/private) and smoking
status.Results
A total of 961 patients who underwent EVAR were
enrolled in the Australian audit. By April 2005, 27% of
this group had died (263/961), and 8% were listed as
lost to follow-up (75/961). Two-year or later follow-up
had been received for over 90% of the remaining
patients (590/623). Patients listed as lost to follow-up
include those who have moved, refused follow-up, or
become too frail to attend follow-up. Some patients
become lost to follow-up when their surgeons retired,
moved or died. During the course of the audit 82
surgeons have contributed data.Pre-operative patient demographics and anatomical features
Most patients in the audit are male (86%, 828/961).
The mean age (GSD) of patients at the time of the
procedure was 75.0G6.9 years and 60% (575/961) of
patients were 75 years or older. Patient fitness was
measured using the American Society of Anaesthe-
siology (ASA) rating. Thirty-four percent of patients
were listed as healthy or had only mild systemic
conditions (i.e. ASA I or II). The number of systemic
conditions diagnosed for patients prior to surgery
ranged from 0 to more than 10 per patient (56%%3
conditions).
Mean pre-operative aneurysm diameter was 57 mm
(G10.4 mm). Where maximum aneurysm diameter
was reported, a total of 44% (410/933) of aneurysmsmeasured less than 55 mm in diameter, with 27%
(255/933) %50 mm in diameter. In the subset of
patients whose aneurysms measured %50 mm, 20%
(52/255) were women.
Ten percent (84/872) of patients had a ‘neck’ length
less than 15 mm. Over 50% of patients had a neck
diameter less than 24 mm. An infrarenal neck diam-
eter R28 mm was recorded in 16% of cases (143/877).
Significant aortic neck angulation (R458) was noted in
13% of patients. An aneurysm angle of R608 was
recorded for 1.5% of patients. Twelve percent
(105/883) of patients had thrombus in the neck of
the aneurysm and 22% had a saccular aneurysm
(187/869).
Forty-three percent of patients (411/961) were
regarded as unsuitable candidates for open repair.
The main reason given was co-existent morbidity
(77%, 316/411). Other reasons given included hostile
abdomen, unfit for general anaesthesia and high risk
of rupture. The patients who were considered fit for
open repair were fitter (ASA I and ASA II 13 vs 51%,
p!0.05) and had fewer co-morbidities (mean number
3.5 vs 2.2; p!0.05).Rupture and aneurysm related deaths
Peri-operative mortality was 1.8% (17/961). A further
nine patients have subsequently died with late (O
30 days) aneurysm-related deaths, bring the total of
aneurysm-related deaths to 2.7% (26/961). Thirteen
patients (1.4%) have had ruptured aneurysms, one
died in the peri-operative period, six died late and six
are surviving following treatment.Technical and clinical success
The overall rate of technical success was 93%
(890/961). It was not possible to distinguish between
planned and unplanned additional endovascular and
surgical procedures performed at the time of graft
deployment.
Rates of clinical success are shown in Table 4. As
several follow-up forms were received for each patient
during the mid-term period (6 month to 5 year),
clinical success was based on the most recent follow-
up. However, if additional endovascular or surgical
procedures had been performed (excluding conver-
sion to open, which constitutes failure) at any time
during the mid-term period then success is described
as assisted or secondary. It should be noted that
patients may fluctuate over time between clinical
failures and successes if, for example, additional
procedures have been performed, a type I endoleakEur J Vasc Endovasc Surg Vol 31, 2 2006
Table 4. Clinical success
Clinical success
(total)
Assisted clinical
success
Secondary clinical
success
Number of type 2
endoleaks with no
increase in sac size
Initial success, nZ961 89% (853) * * 4.6% (41)
Short term success, nZ350 92% (321) 1.7% (6) 1.4% (5) 6.8% (24)
Mid-term success, nZ819 91% (744) 6% (49) 1.5% (12) 4.0% (33)
* Assisted and secondary success is not shown; the questionnaire does not ask whether procedures were planned and unplanned.
M. Boult et al.126disappears or the sac size changes. It should also be
noted that the measure does not include deaths that
are not directly attributable to the procedure (i.e.
deaths occurring more than 30 days post-operatively
from non-aneurysmal related causes are not con-
sidered to be clinical failures). Table 5 shows causes
of mid-term clinical failure.Endoleaks
Prior to discharge, 28/961 patients (3%) were recorded
with type I endoleaks (four of whom also had type II
endoleaks). A further 64/961 patients (6.5%) had type
II endoleaks only. For the group of 24 patients with type
I endoleaks only, 15 reported no leak at next follow-up,
3 were recorded with type II endoleaks only, 4 had
additional procedures performed (one of which
included a conversion to open repair following
rupture), 1 patient died of septicaemia and the outcome
of the last patient is unknown. For the four patients
with type I and II endoleaks, two were clear at next
follow-up and two had ongoing type II endoleaks only.
During mid-term follow-up, 35 patients have been
diagnosed with type I endoleaks. Twenty-four
required additional interventions (including three
patients who were converted to open repair), six
patients declined or were too frail for further
intervention. The leaks resolved in three patients,
however, two died following aneurysm rupture. Ten
patients with type I endoleak also recorded stent
migration.
Type III endoleaks were not originally specified on
the questionnaire, but were added in 2003. To date
only two type III endoleaks have been reported.Table 5. Cause of mid-term clinical failure
Mid term (nZ819)
Increase in sac size R5 mm 25
Endoleak type II and increase
in sac size R5 mm
14
Endoleak type I 8
Conversion to open 7
Migration 1
Broken wires 1
Eur J Vasc Endovasc Surg Vol 31, 2 2006One patient died at 24 months when an intrasac
injection dislodged the contra limb. The second was
diagnosed at 48 months and an extension limb was
inserted endoluminally.Changes in aneurysm sac size
Fig. 1 shows changes in aneurysm size over time.
Aneurysms were deemed to be the same size if they
were within 5 mm of the original (pre-operative)
measurement. After 1 year the bulk of aneurysms are
smaller then their pre-operative size, however, an
increasing proportion of patients (10% at O3 years)
have aneurysms that are R5 mm larger than their pre-
operative size.Additional interventions
Three types of intervention are reported:
† additional procedures performed at the time of the
original procedure (often referred to as secondary
procedures)
† interventions performed after the initial procedure
but prior to discharge
† interventions recorded at follow-upFig. 1. Changes in aneurysm size (G5 mm).
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whose endoluminal repair has been converted to open
repair. Of these, 10 (1.0%) had early conversions
(!30 days post-operative) and 6 (0.6%) had a late
conversion (11–52 months).
At the time of the procedure 24% (226/961)
patients underwent an additional endovascular
procedure and 4% (37/961) patients had an
additional surgical procedure. An additional 1.7%
of patients had endovascular interventions following
the original procedure but prior to discharge
(16/961), and 1.8% had surgical interventions
(17/961).
Table 6 shows the number of open and endovas-
cular interventions reported at follow-up. The
number of follow-up forms received varies for
each period and is highest during the first year
due to increased reporting requirements during this
time interval. Most interventions carried out
following the original procedure were performed
endoluminally.Statistical analysis of results
1. What variables affect likelihood of complications or
re-intervention following EVAR?
The risk of complications or re-interventions
occurring prior to discharge is significantly (i.e. p!
0.05) affected by a higher ASA value (p!0.001), high
number of pre-existing comorbidities (p!0.001), non-
suitability for open repair (p!0.001), older age (p!
0.001), larger pre-operative aneurysm size (pZ0.031)
and post-EVAR increase of sac size (pZ0.036).
The risk of complications or re-interventions
occurring at follow-up is significantly affected by
older age (p!0.001), non-suitability for open repair
(p!0.001), higher ASA value (p!0.001), high number
of pre-existing conditions (pZ0.001), larger pre-
operative aneurysm size (pZ0.006) and greater
aneurysm angulation (pZ0.037).Table 6. Types of intervention reported at follow-up
Open procedures Endoluminal
procedures
!12 months 8 patients:
9 procedures
26 patients;
28 procedures
12–24 months 6 29
24–36 months 6 23 patients;
24 procedures
O36 months 4 20
Number of follow-up forms received: !12 mZ951; 12–24 mZ851;
25–36 mZ528; O36 m 433.2. What morphological variables affect the likelihood
of type I or type II endoleaks?
Shorter infrarenal neck length (pZ0.012), aortic
neck angulation O458 (pZ0.026) and larger pre-
operative aneurysm diameter (pZ0.025) significantly
(p!0.05) affected the likelihood of type I endoleaks.
Analysis showed that patients with a type I
endoleak had significantly shorter neck lengths
(21 mm) than those without a type I endoleak
(26 mm).
Significant relationships were found between type
II endoleaks and male gender (pZ0.007), and higher
ASA values (pZ0.039). The average ASA value for
those with no type II endoleaks was 2.69 and 2.85 for
those with type II endoleaks.
3. Does presence of type I or type II endoleak affect
the likelihood of another procedure?
As would be expected, both Fisher’s test and
logistic regression suggest that type I endoleaks
significantly contribute to explain the variation in
additional interventions. However, it also was
observed that type II endoleaks significantly affect
the likelihood of a patient requiring another procedure
(p!0.001 for both tests).
4. What variables affect technical success and 30-day
clinical success
Table 7 shows the factors most likely to result in
technically and clinically successful repairs. An
aortic neck angle of R458 significantly affects
technical success and initial and mid-term clinical
success.Discussion
The Australian audit of endoluminal repair provides a
population-based overview of mid-term outcomesTable 7. Variables affecting clinical and technical success
Technical
success
Clinical success
Initial Mid-term
Aortic neck angle (R45) 0.008 0.047 0.007
Aneurysm diameter 0.033
Age 0.045
Infrarenal neck length 0.027
Modified ‘White’s
grading system’
0.014
Statistical significance is indicated on table above, by p-values !0.05
(5%).
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and initial clinical success was 89%. Mid-term success
is around 93%, the increased figure due to adjunctive
treatment and a smaller pool of patients.
The cohort of patients entering the audit has similar
demographic/pre-operative characteristics to those
reported for audits elsewhere4,5 and peri-operative
mortality is very similar to that reported in the
DREAM (1.2%) and EVAR-1 (1.7%) trials.6,7 The
major difference between the Australian and European
audits is the type of graft used, with the Zenith graft
(Cook, Australia) being used in 86% of cases
performed in Australia. The Zenith graft appears to
be increasingly frequently used in Europe4 (35%,
2170/6264).
When the use of endoluminally placed grafts for
the treatment of abdominal aortic aneurysms was
first adopted into the repertoire of vascular
surgeons, the main use mooted was for the
treatment of older frailer patients who, it was
deemed, would not be able to undergo the open
procedure. Results from the Australian audit have
shown that in many cases the treatment is being
used for smaller aneurysms (i.e. %50 mm) in fitter
patients (as measured by ASA).8,9 In this paper, we
have attempted to assess those factors which most
affect the mid-term outcomes. Results show that the
likelihood of complications or re-interventions
occurring at follow-up are linked to factors such
as older age, non-suitability for open repair, higher
ASA values, higher number of pre-existing con-
ditions, larger pre-operative aneurysm size and
aneurysm angle of O458. Apart from the larger
aneurysm angle, all the other factors are those,
which would incline a surgeon towards performing
the procedure endoluminally. Surgeons and patients
should therefore be aware, that these patients are at
increased risk of requiring additional procedures or
suffering complications.
The risk of developing type I endoleaks appears to
be linked to shorter infrarenal neck length, aortic neck
angulation O458 and larger pre-operative aneurysms
whilst the risk of developing type II endoleaks is
affected by larger ASA values and being male. In 2001,
after reviewing 238 patient records, Stanley et al.
reported that short neck length, contour and neck
diameter were the most important criteria relating to
the development of endoleak.10 Not surprisingly, the
audit results also show a strong link between the
presence of type I and type II endoleaks and the
likelihood of another procedure. Our recommendation
would be that surgeons are aware of the risk of more
challenging patient morphology as a predictor of
developing type I endoleaks.Eur J Vasc Endovasc Surg Vol 31, 2 2006Lastly, we analysed variables affecting the out-
comes of technical and clinical success as defined by
Chaikof et al.2 The major factors resulting in technical
failure were aortic neck angle R458, shorter infra-
renal neck length and larger pre-operative aneurysm
diameter. Clinical failure was driven by smaller
reductions in sac size, aortic neck angles R458,
older age and patients with higher modified ‘Whites
grading system’ scores.
These anatomical features are clearly important in
predicting those patients likely to require intervention
during follow-up to maintain aneurysm sac
exclusion.
The increasing proportion of patients with sac size
enlarging by 5 ml or more during follow-up (10% at O
3 years) reinforces the importance of regular surveil-
lance of individuals who have undergone this
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